Switching to Rosuvastain Versus Adding Ezetimibe to Atorvastatin Versus Doubling the Dose of Atorvastatin in Patients With Hypercholesterolemia and Risk Factors (P03708)
This study has been terminated.
( Slow enrollment [HIGH SCREEN FAILURE RATE] )
Study NCT00651378
Information provided by Schering-Plough
First Received: March 31, 2008
Last Updated: April 1, 2008
History of Changes
Related Studies can be found by searching for the Conditions, Interventions, and Sponsors found in this study:
